====== Cryptotanshinone 12μM R05 exp227 ======
==== Mechanism of Action ====
Putative acetylcholinesterase and STAT3 inhibitor
* **Class / Subclass 1:** Uncharacterized Mechanism / Natural Product
==== Technical Notes ====
* **PubChem Name:** %%Cryptotanshinone%%
* **Synonyms:** Cryptotanshinon; Tanshinone c
* **CAS #:** 35825-57-1
* **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/160254|160254]]
* **IUPAC:** %%(1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[1,2-g][1]benzofuran-10,11-dione%%
* **INCHI Name:** InChI=1S/C19H20O3/c1-10-9-22-18-12-6-7-13-11(5-4-8-19(13,2)3)15(12)17(21)16(20)14(10)18/h6-7,10H,4-5,8-9H2,1-3H3/t10-/m0/s1
* **INCHI Key:** GVKKJJOMQCNPGB-JTQLQIEISA-N
* **Molecular Weight:** 296.4
* **Canonical SMILES:** CC1COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C
* **Isomeric SMILES:** C[C@H]1COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C
* **Molecular Formula:** C19H20O3
{{:chemogenomics:structures:chem-0132.svg?nolink}}
* **Supplier Name:** Sigma-Aldrich
* **Catalog #:** 79852
* **Lot #:** BCBQ7422V
* **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C19H20O3 297.14852; found 297.14755
* **Platform ID:** Crypto_Tanshione
* **Min:** -4.8129; **Max:** 62.3766
{{:chemogenomics:dose_response:dr_200.png?nolink&500 |}}
\\
\\
\\
\\
|< 300px 100px 200px >|
^ IC ^ Concentration (µM) ^
| IC10 |N/A |
| IC20 |8.3941 |
| IC30 |10.8771 |
| IC40 |13.4513 |
| IC50 |16.3465 |
| IC60 |N/A |
| IC70 |N/A |
| IC80 |N/A |
| IC90 |N/A |
\\
==== Screen Summary ====
* **Round**: 05
* **Dose**: 12µM
* **Days of incubation**: 8
* **Doublings**: 2.4
* **Numbers of reads**: 18040255
==== Screen Results ====
^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^
|34/10|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/Cryptotanshinone_12uM_Round-5_exp227.txt|Scores]]||||||
{{:chemogenomics:cranks_plots:exp227.png?nolink}}
^Gene^CRANKS Score^FDR^
|[[:human_genes:S:SLC39A11|SLC39A11]]|-4.62|<0.01|
|[[:human_genes:N:NPRL2|NPRL2]]|-3.80|<0.01|
|[[:human_genes:P:PRDX1|PRDX1]]|-3.77|<0.01|
|[[:human_genes:P:PCYT1A|PCYT1A]]|-3.37|<0.01|
|[[:human_genes:U:UNC50|UNC50]]|-3.21|<0.01|
|[[:human_genes:S:SLC39A9|SLC39A9]]|-3.17|<0.01|
|[[:human_genes:G:GPR107|GPR107]]|-3.15|<0.01|
|[[:human_genes:I:INTS12|INTS12]]|-3.10|<0.01|
|[[:human_genes:A:ATP6V0A2|ATP6V0A2]]|-3.05|<0.01|
|[[:human_genes:P:PRKAA1|PRKAA1]]|-2.87|<0.01|
|[[:human_genes:S:SEC31A|SEC31A]]|-2.81|<0.01|
|[[:human_genes:C:COMMD8|COMMD8]]|-2.79|<0.01|
|[[:human_genes:A:ATP2C1|ATP2C1]]|-2.76|<0.01|
|[[:human_genes:C:COG7|COG7]]|-2.74|<0.01|
|[[:human_genes:S:SLC25A28|SLC25A28]]|-2.66|<0.01|
|[[:human_genes:G:GID8|GID8]]|-2.63|0.01|
|[[:human_genes:A:ANKH|ANKH]]|-2.57|0.01|
|[[:human_genes:A:ARL1|ARL1]]|-2.56|0.01|
|[[:human_genes:T:TSC2|TSC2]]|-2.56|0.01|
|[[:human_genes:A:ARFRP1|ARFRP1]]|-2.55|0.01|
|[[:human_genes:C:CLCN3|CLCN3]]|-2.52|0.01|
|[[:human_genes:X:XPR1|XPR1]]|-2.51|0.01|
|[[:human_genes:C:CCDC22|CCDC22]]|-2.51|0.01|
|[[:human_genes:C:CNOT8|CNOT8]]|-2.51|0.01|
|[[:human_genes:S:STARD7|STARD7]]|-2.49|0.03|
|[[:human_genes:A:ATP6V1G1|ATP6V1G1]]|-2.49|0.03|
|[[:human_genes:M:MSI2|MSI2]]|-2.49|0.01|
|[[:human_genes:Y:YPEL5|YPEL5]]|-2.48|0.01|
|[[:human_genes:N:NPRL3|NPRL3]]|-2.45|0.06|
|[[:human_genes:C:CHKA|CHKA]]|-2.42|0.02|
|[[:human_genes:P:PELO|PELO]]|2.05|0.30|
|[[:human_genes:P:POLA1|POLA1]]|2.05|0.66|
|[[:human_genes:R:RPS8|RPS8]]|2.05|0.71|
|[[:human_genes:S:STPG1|STPG1]]|2.11|0.28|
|[[:human_genes:U:UBN2|UBN2]]|2.13|0.18|
|[[:human_genes:N:NDUFB8|NDUFB8]]|2.16|0.41|
|[[:human_genes:S:SERPINC1|SERPINC1]]|2.19|0.25|
|[[:human_genes:F:FAM98B|FAM98B]]|2.22|0.12|
|[[:human_genes:I:IBA57|IBA57]]|2.23|0.12|
|[[:human_genes:T:TFDP1|TFDP1]]|2.25|0.28|
|[[:human_genes:P:PPA1|PPA1]]|2.30|0.28|
|[[:human_genes:B:BCL11A|BCL11A]]|2.31|0.08|
|[[:human_genes:T:TTF2|TTF2]]|2.32|0.08|
|[[:human_genes:N:NGDN|NGDN]]|2.35|0.30|
|[[:human_genes:C:C19orf43|C19orf43]]|2.38|0.11|
|[[:human_genes:R:RPS13|RPS13]]|2.40|0.49|
|[[:human_genes:R:RABGAP1|RABGAP1]]|2.42|0.06|
|[[:human_genes:R:RPSA|RPSA]]|2.45|0.47|
|[[:human_genes:T:TGFBR1|TGFBR1]]|2.46|0.05|
|[[:human_genes:M:MCL1|MCL1]]|2.46|0.08|
|[[:human_genes:S:SRM|SRM]]|2.49|0.08|
|[[:human_genes:S:SLFN11|SLFN11]]|2.56|0.03|
|[[:human_genes:T:TP53|TP53]]|2.72|0.03|
|[[:human_genes:N:NFYC|NFYC]]|2.77|0.01|
|[[:human_genes:G:GLRX5|GLRX5]]|2.91|0.01|
|[[:human_genes:E:EIF4A1|EIF4A1]]|3.04|<0.01|
|[[:human_genes:S:SHMT2|SHMT2]]|3.09|0.01|
|[[:human_genes:M:METTL1|METTL1]]|3.17|<0.01|
|[[:human_genes:M:MAT2B|MAT2B]]|3.47|<0.01|
|[[:human_genes:A:ATIC|ATIC]]|4.90|<0.01|
^Screen^Correlation^Plot^
|[[:results:exp517|Quercetin 20μM R08 exp517]]|0.073||
|[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|0.073||
|[[:results:exp359|FK-506 30μM R07 exp359]]|0.072||
|[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|0.07||
|[[:results:exp350|Deferoxamine 11μM R07 exp350]]|0.063||
|[[:results:exp416|Tubacin 1.6μM R07 exp416]]|0.062||
|[[:results:exp90|WYE-354 6μM R02 exp90]]|0.061||
|[[:results:exp435|JQ1 0.8μM R08 exp435]]|0.06||
|[[:results:exp436|Dynasore 7μM R08 exp436]]|0.059||
|[[:results:exp180|Dynasore 10μM R04 exp180]]|0.059||
|[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|0.057||
|[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|0.057||
|[[:results:exp78|Pterostilbene 16μM R02 exp78]]|0.054||
|[[:results:exp85|UM0129480 7μM R02 exp85]]|0.053||
|[[:results:exp399|Salubrinal 20μM R07 exp399]]|0.053||
|[[:results:exp483|FTY720 3μM R08 exp483]]|0.051||
|[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|0.086||
|[[:results:exp461|BS-181 20μM R08 exp461]]|0.077||
|[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|0.065||
|[[:results:exp169|BH1 1μM R04 exp169]]|0.064||
|[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|0.063||
|[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|0.062||
|[[:results:exp468|CB-5083 0.4μM R08 exp468]]|0.059||
|[[:results:exp67|BVD-523 15μM R02 exp67]]|0.058||
|[[:results:exp465|Cannabidiol 13μM R08 exp465]]|0.056||
|[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|0.054||
|[[:results:exp466|Cannabidiol 20μM R08 exp466]]|0.053||
|[[:results:exp450|Artemisinin 50μM R08 exp450]]|0.053||
|[[:results:exp457|Bisphenol F 50μM R08 exp457]]|0.053||
|[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|0.051||
|[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|0.051||
{{:chemogenomics:comparison_plots:exp227_vs_exp517.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp329.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp359.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp445.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp350.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp416.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp90.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp435.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp436.png?nolink |}}
{{:chemogenomics:comparison_plots:exp180_vs_exp227.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp356.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp89.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp78.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp85.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp399.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp483.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp454.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp461.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp68.png?nolink |}}
{{:chemogenomics:comparison_plots:exp169_vs_exp227.png?nolink |}}
{{:chemogenomics:comparison_plots:exp175_vs_exp227.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp321.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp468.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp465.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp334.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp466.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp450.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp457.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp312.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp440.png?nolink |}}
^GO Term^Fold Change^Genes^
|GATOR1 complex|591.79|NPRL2,NPRL3|
|protein localization to Golgi apparatus|61.22|COG7,ARL1,ARFRP1|
|transition metal ion transmembrane transporter activity|57.74|SLC39A11,SLC39A9,ATP2C1,SLC25A28|
|negative regulation of TORC1 signaling|57.74|NPRL2,PRKAA1,TSC2,NPRL3|
|negative regulation of TOR signaling|35.87|NPRL2,PRKAA1,TSC2,NPRL3|
|regulation of TORC1 signaling|27.52|NPRL2,PRKAA1,TSC2,NPRL3|
|transition metal ion transport|25.18|SLC39A11,SLC39A9,ATP2C1,SLC25A28|
|cellular response to starvation|17.51|NPRL2,PRKAA1,TSC2,XPR1,NPRL3|
|response to starvation|14.23|NPRL2,PRKAA1,TSC2,XPR1,NPRL3|
|cellular response to nutrient levels|12.81|NPRL2,PRKAA1,TSC2,XPR1,NPRL3|
|regulation of autophagy|10.20|NPRL2,ATP6V0A2,PRKAA1,TSC2,ATP6V1G1,NPRL3|
|inorganic ion homeostasis|10.10|SLC39A9,ATP6V0A2,ATP2C1,ANKH,XPR1,CCDC22,ATP6V1G1|
|cellular homeostasis|9.30|PRDX1,SLC39A9,ATP6V0A2,PRKAA1,ATP2C1,ANKH,CLCN3,XPR1,CCDC22,ATP6V1G1|
|intracellular chemical homeostasis|8.95|SLC39A9,ATP6V0A2,PRKAA1,ATP2C1,CLCN3,XPR1,CCDC22,ATP6V1G1|
|monoatomic cation homeostasis|8.72|SLC39A9,ATP6V0A2,ATP2C1,ANKH,CLCN3,CCDC22,ATP6V1G1|
|monoatomic ion homeostasis|8.56|SLC39A9,ATP6V0A2,ATP2C1,ANKH,CLCN3,CCDC22,ATP6V1G1|
|inorganic molecular entity transmembrane transporter activity|7.94|SLC39A11,SLC39A9,ATP6V0A2,ATP2C1,SLC25A28,ANKH,CLCN3,XPR1,ATP6V1G1|
|inorganic ion transmembrane transport|7.44|SLC39A11,SLC39A9,ATP6V0A2,ATP2C1,SLC25A28,ANKH,CLCN3,XPR1,ATP6V1G1|
|chemical homeostasis|6.39|SLC39A9,ATP6V0A2,PRKAA1,ATP2C1,ANKH,CLCN3,XPR1,CCDC22,ATP6V1G1|
No GO term hits below threshold. (FDR <0.05)